title: [Safety limit of our myocardial protection method, and possibility of glutamate enriched asanguineous secondary cardioplegia].
authors.forename: E
authors.initials: E
authors.lastname: Shibata
authors.forename: F
authors.initials: F
authors.lastname: Andou
authors.forename: H
authors.initials: H
authors.lastname: Akagawa
authors.forename: I
authors.initials: I
authors.lastname: Yanagi
authors.forename: H
authors.initials: H
authors.lastname: Shima
authors.forename: M
authors.initials: M
authors.lastname: Yamashita
authors.forename: A
authors.initials: A
authors.lastname: Ouryouji
authors.forename: T
authors.initials: T
authors.lastname: Isomura
authors.forename: H
authors.initials: H
authors.lastname: Hara
authors.forename: K
authors.initials: K
authors.lastname: Kosuga
mesh_terms: D000818:Animals; D002314:Cardioplegic Solutions; D004285:Dogs; D004734:Energy Metabolism; D006324:Heart Arrest, Induced / Q000379:methods*; D019344:Lactic Acid / Q000378:metabolism; D015428:Myocardial Reperfusion Injury / Q000517:prevention & control; D009206:Myocardium / Q000378:metabolism; D010101:Oxygen Consumption; D012449:Safety; D012970:Sodium Glutamate; D013997:Time Factors; D016277:Ventricular Function, Left
chemical_list: D002314:Cardioplegic Solutions; D019344:Lactic Acid; D012970:Sodium Glutamate